Breaking News Instant updates and real-time market news.

SHOP

Shopify

$449.98

1.32 (0.29%)

, CGEN

Compugen

$6.04

0.22 (3.78%)

10:12
01/16/20
01/16
10:12
01/16/20
10:12

Fly Intel: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Shopify (SHOP) initiated with a Hold at Loop Capital. 2. Compugen (CGEN) initiated with an Overweight at Cantor Fitzgerald. 3. Vodafone (VOD) reinstated with a Buy at Goldman Sachs. 4. Sunrun (RUN) initiated with an Overweight at JPMorgan. 5. Colfax (CFX) reinstated with a Buy at Goldman Sachs. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

SHOP

Shopify

$449.98

1.32 (0.29%)

CGEN

Compugen

$6.04

0.22 (3.78%)

VOD

Vodafone

$20.26

-0.16 (-0.78%)

RUN

Sunrun

$16.12

0.92 (6.05%)

CFX

Colfax

$38.32

1.06 (2.84%)

SHOP Shopify
$449.98

1.32 (0.29%)

01/09/20
MZHO
01/09/20
INITIATION
Target $410
MZHO
Neutral
Shopify initiated with a Neutral at Mizuho
Mizuho analyst Siti Panigrahi initiated coverage of Shopify with a Neutral rating and $410 price target. Panigrahi said that the company is "well-positioned" to maintain "robust" revenue growth as it has "easy to use" products and favorable secular trends. The analyst added that while he has a positive bias towards the company, he does not expect much upside in the stock price from the current level after a 215% uptick in 2019, and the shares trading at an all-time high valuation multiple.
01/16/20
LOOP
01/16/20
INITIATION
Target $420
LOOP
Hold
Loop Capital starts Shopify at Hold with 'robust' growth outlook priced in
Loop Capital analyst Anthony Chukumba last night initiated coverage of Shopify with a Hold rating and $420 price target. While Shopify provides a "compelling merchant value proposition," has a fast-growing total addressable market, and has opportunities to increasingly provide additional products and services to its merchants, the company's "robust" long-term earnings growth prospects are fully reflected in its stock price at current levels, Chukumba tells investors in a research note. As such, the analyst would wait for a more attractive entry point before becoming more constructive on the stock.
01/15/20
LOOP
01/15/20
INITIATION
Target $420
LOOP
Hold
Shopify initiated with a Hold at Loop Capital
Loop Capital analyst Anthony Chukumba initiated coverage of Shopify with a Hold rating and $420 price target.
01/13/20
FBCO
01/13/20
NO CHANGE
Target $450
FBCO
Outperform
Shopify price target raised to $450 from $370 at Credit Suisse
Credit Suisse analyst Brad Zelnick raised his price target for Shopify to $450 from $370 as he anticipates it will continue to execute against its secular growth opportunities in 2020 and given his updated DCF. The analyst has an Outperform rating on the shares.
CGEN Compugen
$6.04

0.22 (3.78%)

01/15/20
CANT
01/15/20
INITIATION
Target $10
CANT
Overweight
Compugen initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald initiated coverage of Compugen with an Overweight rating and $10 price target.
01/16/20
CANT
01/16/20
INITIATION
Target $10
CANT
Overweight
Cantor 'cautiously positive' on Compugen, starts with Overweight rating
Cantor Fitzgerald analyst Varun Kumar last night initiated coverage of Compugen with an Overweight rating and $10 price target. The analyst is "cautiously positive" on the Compugen story and sees it as a high-risk/high-reward play in the next 12-18 months. A large biopharma company may be willing to form a more matured and strategic partnership around COM701 asset post the second half of 2020 combo/first half of 2021 single-agent data if results support PVRIG as a potential first-in-class immuno-oncology agent, Kumar tells investors in a research note.
VOD Vodafone
$20.26

-0.16 (-0.78%)

09/11/19
EXAN
09/11/19
UPGRADE
EXAN
Outperform
Vodafone upgraded to Outperform from Neutral at Exane BNP Paribas
Exane BNP Paribas analyst Samuel McHugh upgraded Vodafone to Outperform from Neutral.
10/22/19
ARGS
10/22/19
NO CHANGE
Target $23
ARGS
Buy
Vodafone price target raised to $23 from $19 at Argus
Argus analyst John Eade raised his price target on Vodafone to $23 and kept his Buy rating, citing the company's "solid" balance sheet", attractive 5% dividend yield in the current low-rate environment, and its diversified portfolio. The analyst further notes Vodafone's efforts to transform itself from a "pure-play" mobile operator to a company offering a mix of communications services, including fixed broadband, video content, cloud and website hosting, which he expects to boost its earnings amid rising data traffic and growing customer base.
11/11/19
LEHM
11/11/19
DOWNGRADE
LEHM
Underweight
Deutsche Telekom downgraded to Underweight from Equal Weight at Barclays
Barclays analyst Simon Coles downgraded Deutsche Telekom (DTEGY) to Underweight from Equal Weight with a price target of 14 euros, down from 17.60 euros. The analyst sees risk of customer losses given the company's lack of investment in fiber-to-home technology. Vodafone (VOD) and Telefonica Deutschland (TELDF) will offer faster service in at least 60% of Germany, Coles tells investors in a research note.
01/15/20
GSCO
01/15/20
INITIATION
Target $190
GSCO
Buy
Vodafone reinstated with a Buy at Goldman Sachs
Goldman Sachs analyst Andrew Lee reinstated coverage of Vodafone with a Buy rating and 190 GBp price target. The analyst contends that the company offers superior returns and free cash flow to sales ratio relative to its sector average, which should drive the re-rating in the stock. Lee also points to Vodafone's superior ROIC improvement and faster deleveraging vs. the sector average.
RUN Sunrun
$16.12

0.92 (6.05%)

01/16/20
JPMS
01/16/20
INITIATION
Target $19
JPMS
Overweight
Sunrun initiated with an Overweight at JPMorgan
JPMorgan analyst Mark Strouse initiated coverage of Sunrun with an Overweight rating and $19 price target. The shares should attract investors looking for exposure to the de-carbonization, decentralization, and digitization of energy, Strouse tells investors in a research note. He believes Sunrun is well positioned within the "high-growth" U.S. residential rooftop solar market, adding that its leading scale could present adjacent opportunities for growth.
08/20/19
08/20/19
INITIATION
Target $13

Overweight
KeyBanc bullish on Sunnova Energy, initiates with an Overweight
As previously reported, KeyBanc analyst Sophie Karp initiated Sunnova Energy (NOVA) with an Overweight and $13 price target. The analyst notes that shares of Sunnova lie somewhere in between Vivint Solar (VSLR) and Sunrun (RUN) in terms of the margin of safety, since the net value of Sunnova's existing portfolio of assets amounts to about $9/share. Karp believes Sunnova boasts the most significant operating leverage owing to its dealer-only operating model, and expects it to grow aggressively in the 2019-2020 time-frame.
11/13/19
ROTH
11/13/19
NO CHANGE
Target $18
ROTH
Buy
Sunrun price target lowered to $18 from $24 at Roth Capital
Roth Capital analyst Philip Shen lowered his price target for Sunrun to $18 from $24 following the company's quarterly results. In a research note to investors, Shen says that although growth may still be low-to-mid-teens, he believes this labor situation may take longer-than-expected to resolve thereby preventing Sunrun from fully benefiting from the outsized market growth that he sees. He maintains a Buy rating given Sunrun's leadership in grid services and pioneering the utility of the future, despite the growth challenges ahead.
08/20/19
08/20/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Immunomedics (IMMU) initiated with an Overweight at Cantor Fitzgerald. 2. PayPal (PYPL) initiated with a Buy at Rosenblatt while Square (SQ) was initiated with a Neutral. 3. Sunrun (RUN), Vivint Solar (VSLR), and Sunnova Energy (NOVA) initiated with an Overweight at KeyBanc. 4. Spotify (SPOT) initiated with an Equal Weight at Consumer Edge. 5. Silk Road Medical (SILK) initiated with a Buy at Argus. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
CFX Colfax
$38.32

1.06 (2.84%)

12/19/19
BARD
12/19/19
NO CHANGE
Target $42
BARD
Outperform
Colfax long term opportunity remains attractive, says Baird
Baird analyst Michael Halloran said the long term opportunity for Colfax remains attractive as he believes it can achieve low to mid-teens earnings growth on revenue growth of 3-5%. The analyst attended its Analyst Day and said he views its guidance as a realistic starting point with margins a potential upside lever and the pace of a second half recovery a key swing factor however, execution remains the key. Halloran reiterated his Outperform rating and raised his price target to $42 from $39 on Colfax shares.
12/17/19
12/17/19
UPGRADE

BofA ups Eaton, Parker-Hannifin, Colfax, Rexnord in Multi-Industry shuffle
As previously reported, BofA/Merrill analyst Andrew Obin upgraded Eaton (ETN), Parker-Hannifin (PH) and Colfax (CFX), all to Buy from Neutral, and double upgraded Rexnord (RXN) to Buy from Underperform as he shuffled his ratings in the Multi-Industry sector. The impacts of tariffs, trade tensions, and decelerating global industrial production should fade in 2020, while the United States-Mexico-Canada Agreement will clear the way for possible reshoring of supply chains to North America, contends Obin. His changes in sector ratings reflects a bias towards stocks with cyclical EPS recovery potential and "strong execution," the analyst added.
12/17/19
BOFA
12/17/19
UPGRADE
BOFA
Buy
Colfax upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill analyst Andrew Obin upgraded Colfax to Buy from Neutral.
01/16/20
GSCO
01/16/20
INITIATION
Target $44
GSCO
Buy
Colfax reinstated with a Buy at Goldman Sachs
Goldman Sachs analyst Joe Ritchie reinstated coverage of Colfax with a Buy rating and $44 price target. The company, following the DJO acquisition and the sale of its Air & Gas handling business, has a fundamentally much different portfolio with higher margins, reduced cyclicality and greater growth potential, Ritchie tells investors in a research note.

TODAY'S FREE FLY STORIES

TSM

TSMC

$58.58

-0.18 (-0.31%)

09:16
01/18/20
01/18
09:16
01/18/20
09:16
Periodicals
Taiwan tech stocks can ignore China's bluster for now, Barron's says »

China's government…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KKR

KKR

$31.20

0.7 (2.30%)

, APO

Apollo Global

$50.35

1.26 (2.57%)

09:03
01/18/20
01/18
09:03
01/18/20
09:03
Periodicals
KKR undervalued compared with peers, Barron's says »

KKR (KKR) gained 50% last…

KKR

KKR

$31.20

0.7 (2.30%)

APO

Apollo Global

$50.35

1.26 (2.57%)

ARES

Ares Management

$37.29

0.47 (1.28%)

BX

Blackstone

$60.79

0.62 (1.03%)

CG

Carlyle Group

$33.30

0.36 (1.09%)

HLNE

Hamilton Lane

$67.25

-0.02 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

  • 30

    Jan

  • 31

    Jan

  • 31

    Jan

  • 04

    Feb

  • 04

    Feb

  • 05

    Feb

  • 13

    Feb

  • 17

    Feb

  • 26

    Feb

SPCE

Virgin Galactic

$15.65

0.685 (4.58%)

, TWNK

Hostess Brands

$14.03

0.02 (0.14%)

08:56
01/18/20
01/18
08:56
01/18/20
08:56
Periodicals
'Blank-check' companies hot on Wall Street, Barron's says »

More than a quarter of…

SPCE

Virgin Galactic

$15.65

0.685 (4.58%)

TWNK

Hostess Brands

$14.03

0.02 (0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 04

    Mar

GOOG

Alphabet

$1,480.28

28.34 (1.95%)

, NFLX

Netflix

$339.56

0.89 (0.26%)

08:47
01/18/20
01/18
08:47
01/18/20
08:47
Periodicals
Peacock's pricing might be 'killer feature,' Barron's says »

This week, Peacock…

GOOG

Alphabet

$1,480.28

28.34 (1.95%)

NFLX

Netflix

$339.56

0.89 (0.26%)

CMCSK

Comcast

$0.00

(0.00%)

CMCSA

Comcast

$47.48

0.62 (1.32%)

GOOGL

Alphabet Class A

$1,479.12

29.29 (2.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

  • 22

    Jan

  • 23

    Jan

  • 03

    Feb

  • 03

    Feb

  • 10

    Feb

JWN

Nordstrom

$40.34

-0.15 (-0.37%)

, WMT

Walmart

$114.93

-0.96 (-0.83%)

08:36
01/18/20
01/18
08:36
01/18/20
08:36
Periodicals
Casper IPO highlights tech's promise, troubles, Barron' says »

Mattresses have been…

JWN

Nordstrom

$40.34

-0.15 (-0.37%)

WMT

Walmart

$114.93

-0.96 (-0.83%)

CSPR

Casper Sleep

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

  • 18

    Feb

BA

Boeing

$324.11

-7.89 (-2.38%)

, DDAIF

Daimler AG

$0.00

(0.00%)

08:12
01/18/20
01/18
08:12
01/18/20
08:12
On The Fly
Week in Review: How Trump's policies moved stocks »

Catch up on the top…

BA

Boeing

$324.11

-7.89 (-2.38%)

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$13.76

-0.14 (-1.01%)

VWAGY

Volkswagen

$0.00

(0.00%)

FSLR

First Solar

$53.51

-0.42 (-0.78%)

AAPL

Apple

$318.66

3.33 (1.06%)

DQ

Daqo New Energy

$53.61

-0.025 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 29

    Jan

SPOT

Spotify

$148.20

-3.59 (-2.37%)

18:15
01/17/20
01/17
18:15
01/17/20
18:15
Periodicals
Spotify in talks to acquire The Ringer, WSJ reports »

Spotify is in discussions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

CE

Celanese

$117.54

-0.53 (-0.45%)

18:00
01/17/20
01/17
18:00
01/17/20
18:00
Hot Stocks
Celanese announces acetyl intermediates price increases »

Celanese Corporation will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

BYND

Beyond Meat

$109.20

-1.16 (-1.05%)

17:58
01/17/20
01/17
17:58
01/17/20
17:58
Periodicals
Beyond Meat rival gets green light in Canada, The Star says »

Impossible Foods, a maker…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DBD

Diebold

$11.09

-0.49 (-4.23%)

17:42
01/17/20
01/17
17:42
01/17/20
17:42
Periodicals
Breaking Periodicals news story on Diebold »

Diebold Nixdorf divests…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEF

iShares 7-10 Year Treasury Bond ETF

$111.28

-0.13 (-0.12%)

, SHY

iShares 1-3 Year Treasury Bond

$84.73

-0.005 (-0.01%)

17:32
01/17/20
01/17
17:32
01/17/20
17:32
General news
Weekly CFTC Commitment of Traders highlights »

2-YEAR U.S. TREASURY net…

IEF

iShares 7-10 Year Treasury Bond ETF

$111.28

-0.13 (-0.12%)

SHY

iShares 1-3 Year Treasury Bond

$84.73

-0.005 (-0.01%)

SPY

SPDR S&P 500 ETF Trust

$331.98

1.08 (0.33%)

SLV

iShares Silver Trust

$16.82

0.04 (0.24%)

GLD

SPDR Gold Shares

$146.59

0.29 (0.20%)

FXE

Euro Currency Trust

$105.10

-0.43 (-0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UBSFY

Ubisoft

$0.00

(0.00%)

17:32
01/17/20
01/17
17:32
01/17/20
17:32
Periodicals
Ubisoft to restructure editorial team after difficult 2019, VGC reports »

Ubisoft intends to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 18

    Feb

IMVT

Immunovant

$17.04

-0.01 (-0.06%)

17:27
01/17/20
01/17
17:27
01/17/20
17:27
Syndicate
Breaking Syndicate news story on Immunovant »

Immunovant files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TBLT

ToughBuilt

$0.33

-0.0255 (-7.11%)

17:20
01/17/20
01/17
17:20
01/17/20
17:20
Syndicate
ToughBuilt files to sell common stock, no amount given »

Maxim acted as sole book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYO

Myomo

$0.32

0.0062 (1.98%)

17:18
01/17/20
01/17
17:18
01/17/20
17:18
Conference/Events
Myomo to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

SRRA

Sierra Oncology

$0.40

-0.02 (-4.76%)

17:14
01/17/20
01/17
17:14
01/17/20
17:14
Conference/Events
Sierra Oncology to host virtual special shareholder meeting »

Virtual Special…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

SRNE

Sorrento Therapeutics

$4.26

-0.15 (-3.40%)

17:10
01/17/20
01/17
17:10
01/17/20
17:10
Syndicate
Breaking Syndicate news story on Sorrento Therapeutics »

Sorrento Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKER

Akers Biosciences

$3.45

-0.1 (-2.82%)

17:01
01/17/20
01/17
17:01
01/17/20
17:01
Hot Stocks
Akers Biosciences reaches settlement agreements on two derivative actions »

Akers Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECA

Encana

$4.09

-0.18 (-4.22%)

16:40
01/17/20
01/17
16:40
01/17/20
16:40
Hot Stocks
Encana receives court approval for reorganization »

Encana Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

MBRX

Moleculin Biotech

$0.96

0.0122 (1.29%)

16:38
01/17/20
01/17
16:38
01/17/20
16:38
Syndicate
Breaking Syndicate news story on Moleculin Biotech »

Moleculin Biotech files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VOD

Vodafone

$20.07

-0.225 (-1.11%)

, BT

BT Group

$0.00

(0.00%)

16:37
01/17/20
01/17
16:37
01/17/20
16:37
Periodicals
BT, Vodafone consider urging PM Johnson not to ban Huawei in U.K., Reuters says »

BT Group (BT) and…

VOD

Vodafone

$20.07

-0.225 (-1.11%)

BT

BT Group

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
01/17/20
01/17
16:30
01/17/20
16:30
Options
Preliminary option volume of 28.7M today »

Preliminary option volume…

NSCO

Nesco Holdings

$5.12

0.025 (0.49%)

16:26
01/17/20
01/17
16:26
01/17/20
16:26
Syndicate
Nesco Holdings requests withdrawal of registration statement »

Nesco Holdings has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPS

Gap

$18.54

-0.075 (-0.40%)

, CMCSA

Comcast

$47.48

0.62 (1.32%)

16:20
01/17/20
01/17
16:20
01/17/20
16:20
On The Fly
Fly Intel: Wall Street's top stories for Friday »

The major averages were…

GPS

Gap

$18.54

-0.075 (-0.40%)

CMCSA

Comcast

$47.48

0.62 (1.32%)

CMCSK

Comcast

$0.00

(0.00%)

PLAY

Dave & Buster's

$47.35

5.3 (12.60%)

KKR

KKR

$31.20

0.7 (2.30%)

BA

Boeing

$324.11

-7.89 (-2.38%)

JNJ

Johnson & Johnson

$149.07

0.82 (0.55%)

SWK

Stanley Black & Decker

$172.63

2.18 (1.28%)

TWOU

2U

$22.84

1.05 (4.82%)

BE

Bloom Energy

$9.70

0.43 (4.64%)

MGPI

MGP Ingredients

$38.16

-14.74 (-27.86%)

FAST

Fastenal

$36.77

-0.55 (-1.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 20

    Jan

  • 22

    Jan

  • 23

    Jan

  • 29

    Jan

  • 29

    Jan

  • 31

    Jan

  • 26

    Feb

  • 27

    Feb

  • 09

    Mar

  • 17

    Mar

APLS

Apellis

$40.43

0.03 (0.07%)

16:18
01/17/20
01/17
16:18
01/17/20
16:18
Hot Stocks
Apellis CEO sells 30.6K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.